Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD™-B)

NCT01965145 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Behcet's Uveitis

Interventions

DRUG: Gevokizumab
DRUG: Placebo

Sponsor

Institut de Recherches Internationales Servier